DrugAbacus provides a way of thinking about the how to price drugs. This interactive tool takes more than 50 cancer drugs and lets you compare the company’s price to one based on value.
Assign numbers to each component of value for a drug.
DrugAbacus will show you the results and compare your Abacus prices to the drugs’ actual prices.
Use the pricing components at the bottom of the tool to see how the values affect drug prices.
Margot Sanger-Katz reports on the negative effects of drug coupons, citing a paper written by Dr. Peter Ubel and Dr. Peter Bach that outlines the issue and prescribes policy solutions
Lynne Lederman reports on the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting wasCollective Wisdom: The Future of Patient-Centered Care and Research discussion on value frameworks, as well as the results of a value survey conducted during and after ASCO by ZS […]
The Evidence Driven Drug Pricing Project is led by Dr. Peter Bach in an effort to highlight the on-going problem of rising drug prices. Dr. Peter B. Bach, Director of Memorial Sloan Kettering’s Center of Health Policy and Outcomes, is a physician, epidemiologist, researcher, and respected healthcare policy expert, whose work focuses on the cost and value of anticancer drugs.Read More
Join our mailing list to receive updates from the Evidence Driven Drug Pricing Project.